Gamida Cell (NASDAQ:GMDA – Get Rating) had its target price lifted by HC Wainwright from $5.00 to $11.00 in a research note published on Wednesday, The Fly reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Gamida Cell’s Q1 2023 earnings at ($0.29) EPS, Q2 2023 earnings […]
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Equities researchers at HC Wainwright issued their FY2026 earnings per share (EPS) estimates for Gamida Cell in a research report issued to clients and investors on Wednesday, April 19th. HC Wainwright analyst V. Bernardino forecasts that the company will post earnings per share of $0.90 for the […]
Gamida Cell (NASDAQ:GMDA – Get Rating) had its price objective hoisted by stock analysts at HC Wainwright from $5.00 to $11.00 in a research report issued to clients and investors on Wednesday, The Fly reports. Separately, Oppenheimer cut their price target on shares of Gamida Cell from $10.00 to $8.00 and set an “outperform” rating […]
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 5,140,000 shares, a decline of 7.7% from the February 28th total of 5,570,000 shares. Approximately 9.8% of the shares of the company are short […]
Gamida Cell Ltd. (NASDAQ:GMDA – Get Rating) – Investment analysts at HC Wainwright issued their Q1 2023 earnings per share (EPS) estimates for shares of Gamida Cell in a research report issued to clients and investors on Tuesday, March 28th. HC Wainwright analyst V. Bernardino expects that the company will post earnings per share of […]